Pascal Hilliquin

Corbeil-essonnes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica.

Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: December 23, 2024

Concordance and agreement between different activity scores in polymyalgia rheumatica.

Concordance and agreement between different activity scores in polymyalgia rheumatica.

Journal: RMD open

Published: September 19, 2023

Comparison of Biological Agent Monotherapy and Associations Including Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: Literature Review and Meta-Analysis of Randomized Trials.

Comparison of Biological Agent Monotherapy and Associations Including Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: Literature Review and Meta-Analysis of Randomized Trials.

Journal: Journal of clinical medicine

Published: November 14, 2022

Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.

Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.

Journal: JAMA

Published: September 20, 2022

Changes of anti-citrullinated peptide antibodies titers after biologic treatment in patients with rheumatoid arthritis: a systematic literature review and retrospective study.

Changes of anti-citrullinated peptide antibodies titers after biologic treatment in patients with rheumatoid arthritis: a systematic literature review and retrospective study.

Journal: Clinical and experimental rheumatology

Published: June 23, 2022

Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study.

Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study.

Journal: Rheumatology and therapy

Published: August 27, 2020

Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study.

Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study.

Journal: Arthritis research & therapy

Published: March 01, 2020

Two-year abatacept retention rate in clinical practice in the French ACTION cohort.

Two-year abatacept retention rate in clinical practice in the French ACTION cohort.

Journal: Joint bone spine

Published: June 12, 2019

Thrombotic microangiopathy associated with anti-neutrophil cytoplasmic antibody-associated vasculitis: a French nationwide retrospective case-control study and literature review.

Thrombotic microangiopathy associated with anti-neutrophil cytoplasmic antibody-associated vasculitis: a French nationwide retrospective case-control study and literature review.

Journal: Rheumatology (Oxford, England)

Published: March 22, 2019

Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'.

Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 08, 2017

Title Not Found

Title Not Found

Journal: La Revue du praticien

Published: December 01, 2016

Title Not Found

Title Not Found

Journal: La Revue du praticien

Published: December 01, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026